Schedule 13D ownership disclosure

ENVVENO MEDICAL CORPORATION

Common Stock, par value $0.00001 per share · CUSIP: 29415J205

Event date: 2026-02-20

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Braeden LichtiReported CIK 0001982476

    Shares: 33,151.00 · Class: 5.05%

  • Northstrive Fund II LPReported CIK 0002099270

    Shares: 20,129.00 · Class: 3.07%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-26-018626
Form type
SCHEDULE 13D
Filer
Braeden Lichti
CIK
CIK 1982476
Filed
Feb 20, 2026
Reporting period
Feb 20, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub